The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With Anthracyclines
Open accessAbstract
We aimed to describe the cardiac magnetic resonance (CMR) findings and to determine prognostic variables in patients with a cardiomyopathy after treatment with anthracyclines. CMR imaging was performed in 91 patients (58% male, mean age of 43 ± 18 years and anthracycline dose of 276 ± 82 mg/m2) with reduced ejection fraction (EF) after anthracycline-based chemotherapy. Major adverse cardiovascular events (MACE) were defined as cardiovascular death, appropriate implantable cardioverter defibrillator therapy, and admission for decompensated heart failure. Patients presented a median of 88 months (IQR 37 to 138) after chemotherapy and were followed for 27 months (IQR 22 to 38). Late gadolinium enhancement was an uncommon finding (5 patients, 6%) despite a reduced EF (36 ± 8%). There was an inverse association between anthracycline dose and the indexed left ventricular (LV) mass by CMR (r = −0.67, p < 0.001). There were 52 adverse cardiac events (event rate of 22% per year). When patients were grouped according to the presence or absence of a MACE, indexed LV mass and glomerular filtration rate were lower and anthracycline dose was higher among patients that experienced an adverse event. In a multivariable model, indexed LV mass demonstrated the strongest association with MACE (HR = 0.89, chi-squared = 26, p < 0.001). In conclusion, scar by LGE-CMR imaging is infrequent in patients with an anthracycline-induced cardiomyopathy despite a reduced EF, the event rate in patients with an established anthracycline-induced cardiomyopathy is high, and indexed LV-mass by CMR is a predictor of adverse cardiovascular events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471
Cited by
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.07.012 · Cited by 1,795
Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5400 · Cited by 1,290
Self-citationPlana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu192 · Cited by 1,058
Sex differences in heart failure
Lam, C. S. P., Arnott, C., Beale, A. L., Chandramouli, C., Hilfiker-Kleiner, D., Kaye, D. M., Ky, B., Santema, B. T., Sliwa, K., & Voors, A. A. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz835 · Cited by 802
Bloom, M. W., Hamo, C. E., Cardinale, D., Ky, B., Nohria, A., Baer, L., Skopicki, H., Lenihan, D. J., Gheorghiade, M., Lyon, A. R., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002661 · Cited by 334
Metadata
- Authors
- Neilan, T. G., Coelho-Filho, O. R., Pena-Herrera, D., Shah, R. V., Jerosch-Herold, M., Francis, S. A., Moslehi, J., & Kwong, R. Y.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 110
- Issue
- 11
- Pages
- 1679-1686
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2167777123
- Cited by
- 224
- References
- 2
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.